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Heparan sulfate proteoglycans (HSPGs) are an
important constituent of the macrophage glycocalyx
and extracellular microenvironment. To examine
their role in atherogenesis, we inactivated the
biosynthetic gene N-acetylglucosamine N-deacety-
lase-N-sulfotransferase 1 (Ndst1) in macrophages
and crossbred the strain to Ldlr/ mice. When
placed on an atherogenic diet, Ldlr/Ndst1f/f
LysMCre+ mice had increased atherosclerotic pla-
que area and volume compared to Ldlr/ mice.
Diminished sulfation of heparan sulfate resulted
in enhanced chemokine expression; increased
macrophages in plaques; increased expression of
ACAT2, a key enzyme in cholesterol ester storage;
and increased foam cell conversion. Motif analysis
of promoters of upregulated genes suggested
increased type I interferon signaling, which was
confirmed by elevation of STAT1 phosphorylation
induced by IFN-b. The proinflammatory macro-
phages derived from Ndst1f/fLysMCre+ mice also
sensitized the animals to diet-induced obesity. We
propose that macrophage HSPGs control basal
activation of macrophages by maintaining type I
interferon reception in a quiescent state through
sequestration of IFN-b.
INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death glob-
ally, primarily as a result of complications of atherosclerosis. The
complex pathology of atherosclerosis is characterized by the
accumulation of lipids, inflammatory cells, and fibrous elements
in large- and medium-sized arteries (Swirski and Nahrendorf,
2013). According to the ‘‘response-to-retention’’ model, focal
infiltration and retention of apolipoprotein B (apoB)-containing li-
poproteins, such as low-density lipoproteins (LDLs), lipoproteinCell M(a), and triglyceride-rich remnant particles (TRLs), in the suben-
dothelial matrix of the tunica intima of arteries at atheroscle-
rosis-prone sites initiates atherogenesis (Tabas et al., 2007).
Subsequent oxidation, lipolysis, proteolysis, and further aggre-
gation of trapped LDL particles contribute to a chronic inflamma-
tory response characterized by monocyte and T cell migration
into the intima. Monocytes entering the plaque differentiate
into macrophages and the expression of scavenger receptors
result in internalization of modified lipoprotein particles. Lesion
macrophages proliferate, accumulate massive amounts of
cholesterol, and become lipid droplet-loaded ‘‘foam cells,’’ re-
sulting in their retention in the lesion (Robbins et al., 2013; Witz-
tum and Lichtman, 2014).
Proteoglycans consist of a protein core and one or more cova-
lently attached glycosaminoglycan (GAG) chains. Studies of hu-
man diseases and model organisms have demonstrated the
importance of proteoglycans in development and physiology
(Sarrazin et al., 2011). Proteoglycans in the arterial wall help
establish the architecture of the vessel and play roles in smooth
muscle cell and endothelial cell proliferation (Wight, 1989). They
also retain lipoproteins in the arterial wall via interaction of apoB
and possibly other apolipoproteins with the negatively charged
sulfate groups of the GAG chains (Tabas et al., 2007).
Little is known about the in vivo contribution of macrophage-
derived proteoglycans to the development and progression of
atherosclerosis. In vitro experiments have shown that lesion-
derived macrophages produce proretentive proteoglycans and
enhance LDL aggregation (Maor et al., 2000). Recently, we
showed that the heparan sulfate proteoglycan (HSPG) synde-
can-1 mediates uptake and clearance of triglyceride-rich lipo-
proteins in hepatocytes (Stanford et al., 2009). Conceivably,
macrophage proteoglycansmight act in a similar way, facilitating
uptake and clearance of lipoprotein particles, possibly contrib-
uting to foam cell formation in the artery.
In this study we determined the impact on atherosclerosis of
altering the structure of heparan sulfate (HS) in monocytes/mac-
rophages by inactivation of a HS biosynthetic enzyme (Ndst1)
selectively in the myeloid lineage. Contrary to expectations,
the inactivation of Ndst1 exacerbated atherosclerosis in mice
deficient in LDL receptors (Ldlr/). Analysis of inflammatory
markers revealed that macrophages from the mutant were inetabolism 20, 813–826, November 4, 2014 ª2014 Elsevier Inc. 813
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Figure 1. Characterization of Ndst1f/fLysMCre+ Macrophages
(A) qPCR of Ndst1-4 in Ndst1f/fLysMCre+ and wild-type BMDMs (n = 3).
(B) Changes in N-acetylated, N-sulfated, 2-O-sulfated, and 6-O-sulfated HS disaccharide in Ndst1f/fLysMCre+ BMDMs compared to wild-type BMDMs.
(C) Relative FGF-2 binding in BMDMs treated or untreated with heparin lyase III (n = 2). Shown are mean values ± SEM, *p < 0.05, **p < 0.01 and ***p < 0.001.
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cytokines and enhanced macrophage infiltration, foam cell
conversion, and development of atherosclerotic lesions. The
proinflammatory shift also increased diet-induced obesity. We
show that macrophage HSPGs regulate the inflammatory state
in a cell-autonomous fashion by maintaining type I interferon
(IFN) reception in a quiescent state through sequestration of
IFN-b. Together, the data suggest that HSPGs are important
in regulating the threshold for type I interferon stimulation of
macrophages.
RESULTS
Myeloid-Specific Ndst1 Gene Disruption Alters Heparan
Sulfate in Macrophages
HS assembly occurs by the copolymerization of N-acetylglucos-
amine (GlcNAc) and glucuronic acid (GlcA) residues, followed by
a series of processing reactions catalyzed by several sulfotrans-
ferases, an epimerase, and cell-surface sulfatases. Of the four
Ndst isozymes that have been described, only Ndst1 and
Ndst2 are expressed in macrophages (Figure 1A). In order to
determine the impact of altering Ndst1 expression, we crossbred
mice bearing a conditional loxP-flanked (‘‘floxed’’) allele ofNdst1
(Ndst1f/f) to transgenic mice expressing the bacterial Cre recom-
binase under control of the lysozyme 2 promoter (LysMCre) to
drive inactivation of the gene in myeloid cells. Quantitative
PCR (qPCR) analysis of mRNA collected from bone marrow-
derived macrophages (BMDMs) from Ndst1f/fLysMCre+ mice
showed almost complete inactivation (98%) of Ndst1 expres-
sion (Figure 1A), without any compensation by Ndst2-4.
Macrophages express a relatively highly sulfated HS, rich in
trisulfated and disulfated disaccharides (D2S6 and D2S0; see
Figure S1 available online). However, inactivation of Ndst1 in
macrophages induced relatively modest changes in overall HS
composition compared to other cell types (Figure S1) (MacArthur
et al., 2007), decreasing the level of N-sulfation from 53 N-sulfo-
glucosamine residues/100 disaccharides in wild-type macro-
phages to 44/100 disaccharides in the mutant (15% reduction;
Figure 1B), with a corresponding increase in N-acetylglucos-
amine residues from 47/100 disaccharides in the wild-type to814 Cell Metabolism 20, 813–826, November 4, 2014 ª2014 Elsevier55/100 disaccharides in the mutant. The remaining N-sulfoglu-
cosamine residues arose presumably from the action of Ndst2
(Figure 1A). Due to coupling of N-sulfation to downstream
biosynthetic reactions, the number of 2-O-sulfate groups
located on the uronic acids decreased from 46/100 disaccha-
rides in the wild-type to 39/100 disaccharides in the mutant
(14%), and the extent of glucosamine 6-O-sulfation decreased
from 38 sulfates/100 disaccharides in the wild-type to 34/100
disaccharides in the mutant (10%). The modest change in
composition nevertheless significantly diminished binding of
HS-binding ligands, such as FGF2 (40%, Figure 1C).
Myeloid-Specific Ndst1 Gene Disruption Increases
Atherosclerosis
To examine the impact of altering macrophage HS on athero-
sclerosis, we bred Ndst1f/fLysMCre+ mice onto an Ldlr/ back-
ground. In preliminary studies, we found that feeding a high-fat,
high-cholesterol (HFC) diet to themalemice led to greater weight
gain than in female mice. Therefore, to avoid complications of
differential weight gain, we fed female animals a HFC diet for
up to 12 weeks. Total cholesterol and triglyceride levels did
not differ between Ldlr/Ndst1f/fLysMCre+ and Ldlr/Ndst1f/f
LysMCre mice prior to placing the animals on the diet (Figures
2A and 2B). Plasma triglycerides and cholesterol progressively
increased to the same extent in both strains on the HFC diet.
FPLC analysis of plasma taken after 12 weeks demonstrated
equivalent accumulation of chylomicron/VLDL triglycerides and
chylomicron/VLDL and IDL/LDL cholesterol in both strains, while
HDL cholesterol levels were unchanged (Figures 2C and 2D). No
difference in body weight was observed between Ldlr/Ndst1f/f
LysMCre and Ldlr/Ndst1f/fLysMCre+ (24.2 ± 0.8 g [n = 14]
versus 25.0 ± 1.1 g [n = 15]) mice at the end of the feeding period.
Glucose homeostasis between the groups was similar based on
their fasting glucose and insulin levels, although there was a
trend toward higher glucose and lower insulin in the mutant (Fig-
ures 2E and 2F). Glucose tolerance and insulin tolerance were
comparable (Figures 2G and 2H).
En face analysis of atherosclerosis in the aorta showed plaque
formation restricted to the aortic root and arch in both strains
(Figure 2I). However, inactivation of Ndst1 caused a 2-foldInc.
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compared to Ldlr/Ndst1f/fLysMCre controls expressed either
as a percentage of total surface area and by absolute plaque
area (Figure 2J). A similar significant increase was observed in
male mice (Figures S1B and S1C). Aortic root cross-sectional
analysis confirmed that plaque volume in Ldlr/Ndst1f/f
LysMCre+ mice increased as well (Figures 2K and 2L). Visual in-
spection of van Gieson-stained cross-sections of lesions at the
aortic root strongly suggested that plaques from Ldlr/Ndst1f/f
LysMCre+mice had larger necrotic cores (Figure 2M), which was
confirmed by image quantitation (Figure 2N), suggesting that the
lesions were more advanced compared to those in control mice.
Lesions from Ldlr/Ndst1f/fLysMCre+ mice also had a signifi-
cantly higher macrophage content compared to lesions from
control mice (40% of lesion area in the mutant versus 25% in
the wild-type; p < 0.001) (Figure 2M, lower panel, and Figure 2O),
but T cell infiltration was not elevated (Figures S1D–S1F). The
proliferating and apoptotic cell content in the lesions was similar
between the groups as well (Figures S1G–S1J).
ApoE bound to HSPGs controls proliferation of hematopoietic
stem and multipotential progenitor cells in the bone marrow,
monocytosis, and monocyte accumulation in atherosclerotic le-
sions in mice (Murphy et al., 2011). Ldlr/Ndst1f/fLysMCre+ and
Ldlr/Ndst1f/fLysMCre mice showed no difference in mono-
cyte (Figure 2P) or neutrophil counts (Figure 2Q). Also plasma
lymphocyte counts (Figure S1I) and total white blood cell counts
(Figure S1J) did not differ.
These findings suggest that altering macrophage proteogly-
can sulfation exacerbates atherosclerosis and enhances the
number of macrophages in the lesion and lesion composition,
but it does not affect plasma lipoproteins, infiltration of neutro-
phils and T cells, or plasma myeloid or lymphocyte counts.
Macrophage Proteoglycans Modulate Foam Cell
Formation
Macrophage syndecan-4, a type of HSPG, has been implicated
in foam cell conversion in vitro (Boyanovsky et al., 2009). To test
if inactivation of Ndst1, which affects sulfation of all HSPGs
in targeted cells, also reduced foam cell conversion, we
elicited peritoneal macrophages in Ldlr/Ndst1f/fLysMCre+
and Ldlr/Ndst1f/fLysMCre mice fed an HFC diet. In
contrast to these earlier findings, macrophages isolated from
Ldlr/Ndst1f/fLysMCre+ mice stained more intensely with oil
red O and accumulated significantly more cholesterol esters
than Ldlr/Ndst1f/fLysMCre macrophages (Figures 3A–3C).
To examine foam cell conversion in vitro, BMDMs were isolated
and challenged with normal LDL, aggregated LDL (agLDL),
and oxidized LDL (oxLDL). Incubation with agLDL dramatically
induced cholesterol ester accumulation compared to the other
lipoprotein preparations and occurred to a greater extent inmac-
rophages derived from Ndst1f/fLysMCre+ mice than control
mice (Figures 3D and 3E). Treatment of the cells with lipopoly-
saccharide enhanced further the extent of cholesterol ester
accumulation in wild-type macrophages, but did not accentuate
the elevation caused by altering HS (Figure 3F). No gross
changes were observed in free cholesterol levels between
Ndst1f/fLysMCre+ and Ndst1f/fLysMCre macrophages (Figures
S2A–S2D). Macrophages from both male and female mutant
mice responded similarly.Cell MIncubation of BMDM for 1 hr with DiD-agLDL at 4C or 37C
did not show any significant difference in binding or cell associ-
ation (e.g., the sum of binding and uptake) between the two ge-
notypes (Figure 3G). Reverse cholesterol transport, asmeasured
by efflux of 3H-cholesterol to apolipoprotein AI or high-density li-
poproteins (HDLs), was slightly decreased in Ndst1f/fLysMCre+
macrophages compared to controls (Figure 3H), but the differ-
ence did not reflect an alteration in HDL binding (Figure S2E) or
expression of cell-surface ABCA1 transporters and apolipopro-
tein E (Figures S2F and S2G). The small decrease in efflux of
radioactive cholesterol did not correspond to any difference in
total cholesterol ester loss measured chemically, suggesting
that decreased efflux was not the cause for the accumulation
of lipid in the mutant macrophages (Figure 3I).
Ndst1 Deficiency Results in an Inflammatory Gene
Expression Profile
To gain insight into the mechanism underlying the alterations in
the mutant, we compared the transcriptome of BMDMs from
Ndst1f/fLysMCre and Ndst1f/fLysMCre+ macrophages in basal
growth medium (Figure 4A). Increased expression of a relatively
small set of genes occurred in the mutant, treated or untreated
with agLDL, mostly in genes with functional annotations linked
to immunity, defense and inflammatory response (Figure 4B;
Table S1). A comparable number of genes were decreased in
expression, but these were linked to transmembrane signaling
or apoptosis (Figure 4C). qPCR analysis confirmed the enhanced
expression of Ccl2, Ccl5, Ccl7, and Ccl8 (Figure 4D). ELISA
confirmed increased secretion of CCL5 and CCL7 (Figures 4E–
4G). Other inflammatory genes were elevated as well, including
Tnf-a, Ly6a, and Il10 (Figure 4D). LPS treatment of macrophages
greatly amplified the expression of these genes and diminished
the differences in gene expression between mutant and wild-
type seen under basal conditions, with the exception of Ccl5
and Il10 (Figure S3A). While IL10 is an anti-inflammatory cyto-
kine, it is one of the most highly induced genes in classically
activated macrophages following exposure to Toll-like receptor
ligands (Re and Strominger, 2004). Expression of other anti-in-
flammatory markers in mutant macrophages was either reduced
or unaltered compared to wild-type (Figure S3B).
Several of these chemokines act as chemoattractants for
monocytes, thus providing a plausible explanation for the
enhanced content of macrophages in the atherosclerotic lesions
(Figures 2M and 2O). To test if similar changes in gene expres-
sion occurred in vivo, we dissected plaques from the aortic
arch and extracted mRNA for qPCR analysis, correcting tran-
script expression for macrophage content in the tissue (F4/80
expression). The results confirmed significant elevated expres-
sion of inflammatory genes (Ccl2, Ccl7, Ccl8, Tnf-a, and Il6) in
the atherosclerotic plaques with the exception of Ccl5 and Il-
10 (Figure 4I). These findings suggest that the accumulating
lesion macrophages express inflammatory genes and are thus
proinflammatory M1-like (Ly6c-hi) macrophages. To evaluate if
monocyte recruitment was altered, we tagged Ly6c-hi mono-
cytes with fluorescent beads (Tacke et al., 2007) and showed
enhanced accumulation into lesions of Ldlr/Ndst1f/fLysMCre+
mice compared to control mice (Figures 2J and 2K).
ACAT2, an enzyme that converts cholesterol into choles-
terol ester using long-chain fatty acyl-coenzyme A, also wasetabolism 20, 813–826, November 4, 2014 ª2014 Elsevier Inc. 815
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Figure 2. Macrophage NDST1 Inactivation Increases Atherogenesis and Lesion Macrophage Content
Plasma triglycerides and cholesterol levels from female Ldlr/Ndst1f/f and Ldlr/Ndst1f/fLysMCre+ mice at different times after commencing HFC diet feeding
(A and B). FPLC analysis of plasma after 12 weeks of HFC diet feeding (n = 6) (C and D). Fasting plasma glucose and insulin levels before and after an oral glucose
gavage (n = 5–7) (E and F). Glucose tolerance (G) and insulin tolerance (G) tests were performed after 11 weeks of HFC diet feeding (n = 5–7). En face analysis of
(legend continued on next page)
Cell Metabolism
Macrophage HSPGs, Atherosclerosis, and Obesity
816 Cell Metabolism 20, 813–826, November 4, 2014 ª2014 Elsevier Inc.
A B C D E
F G H I
Figure 3. Macrophage Ndst1 Inactivation Increases Foam Cell Conversion
Oil redO staining of peritoneal macrophages collected after 12weeks of HFC diet feeding (A). Oil red O-positive peritoneal macrophages (B) and cholesterol ester
levels (C) in peritoneal macrophages collected after 12 weeks of HFC diet feeding (n = 3/group). Cholesterol ester levels in BMDM after a 24 hr incubation with 0 or
50 mg/ml of LDL, agLDL, and oxLDL (n = 3) (D). Cholesterol ester levels in BMDM after a 24 hr incubation with different concentrations of agLDL (n = 3) (E).
Cholesterol ester levels in BMDM after a 24 hr incubation with 0 or 50 mg/ml of LDL and agLDL in the presence or absence of 100 ng/ml LPS (n = 3) (F). Binding at
4C or uptake at 37C for 1 hr of DiD-agLDL in BMDMs (n = 3) (G). Cholesterol efflux in BMDMs after 24 hr incubation with 10 mg/ml apoAI or 50 mg/ml HDL (n = 3)
(H). Cholesterol ester content in BMDMs after cholesterol efflux with 10 mg/ml apoAI or 50 mg/ml HDL (n = 3) (I). Shown are mean ± SEM, *p < 0.05 and **p < 0.01.
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ern blot analysis of ACAT1 and ACAT2 expression revealed
that both enzymes were significantly increased in Ndst1f/f
LysMCre+macrophages (Figure S3C). Interestingly, the increase
in ACAT1 protein expression did not correlate with increased
Acat1 mRNA levels, except under conditions in which Ndst1f/f
LysMCre+ BMDMs were stimulated with LPS (Figure S3D). Incu-
bation of macrophages with agLDL and the ACAT inhibitor
(ACATi) Sandoz 58-035 blocked accumulation of cholesterol
esters, normalizing the levels in the mutant to that seen in the
wild-type (Figure 4L). Treatment of BMDMs with chloroquine,
which inhibits lysosomal degradation of LDL particles, also pre-
vented cholesterol ester accumulation (Figure 4L). Taken
together, these findings suggest that elevated expression of
both ACAT1 and ACAT2 in Ndst1f/fLysMCre+ enhanced foam
cell conversion.
Myeloid-Specific Ndst1Gene Disruption Promotes Diet-
Induced Obesity
Given the activated state of macrophages in Ndst1f/fLysMCre+
mice, we wondered if the animals also might be susceptible to
diet-induced obesity. Aged-matched male mice on a chow diet
did not show any differences in body weight gain between the
genotypes (Figure 5A). However, when fed a high-fat diet,atherosclerosis and quantification of Sudan IV-positive area (I and J). Staining and
Atherosclerotic lesions stained with van Gieson for collagen or F4/80 for macroph
lesions after 12weeks of HFC diet feeding.Monocyte (P) andNeutrophil (Q) counts
**p < 0.01.
Cell MNdst1f/fLysMCre+ mice were consistently heavier, with a signifi-
cant increase in the rate of weight gain after 6 weeks (Figure 5B).
The increased body weight gain of the mutant mice correlated
with increased mass of white adipose tissue (WAT), brown adi-
pose tissue (BAT), and the liver, whereas other organs such as
muscle were unaffected (Figure 5C). The diameter of the adipo-
cytes in WAT increased as well, consistent with accumulation of
lipid droplets (Figure 5D). Histological analysis revealed that
Ndst1f/fLysMCre+ mice exhibited increased lipid accumulation
in liver, WAT, BAT, and skeletal muscle (Figures 5D and 5E).
The increase in weight gain in mutant mice fed a HFC diet was
not associated with differences in food intake (Figure 5F). Indi-
rect calorimetry measurements at the end of HFC diet showed
a trend toward reduced oxygen consumption and CO2 produc-
tion in Ndst1f/fLysMCre+mice, which translated into a significant
reduction in energy expenditure during the dark phase (Figures
5G–5I). These changes were independent of alterations in respi-
ratory exchange ratio (RER) or activity levels between both
mouse groups (Figures 5J and 5K).
The increase in weight gain on the HFC diet was associated
with pronounced differences in glucose homeostasis between
the groups. Ndst1f/fLysMCre+ mice had elevated fasting plasma
glucose and nonesterified fatty acid (NEFA) levels and ex-
hibited a pronounced hyperinsulinemia before and after glucosequantification of atherosclerotic lesion size in the aortic sinus (n = 5–7) (K and L).
ages (M). Quantification of necrotic core size (N) and F4/80-positive area (O) in
in blood during HFCdiet feeding. Shown aremean values ± SEM, *p < 0.05 and
etabolism 20, 813–826, November 4, 2014 ª2014 Elsevier Inc. 817
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Figure 4. Reducing Macrophage HSPG Sulfation Increases Expression of Inflammatory Genes
Microarray analysis on RNA isolated from BMDMs (n = 4/group). Gene expression was filtered for genes from untreated Ndst1f/fLysMCre+ BMDMs at
least 2-fold different from WT control (A). Venn diagram of >1.53 upregulated genes (B) and <1.53 downregulated genes (C) and their overlap by agLDL
treatment in the transcriptome of wild-type and Ndst1f/fLysMCre+ BMDMs, and p values for selected gene ontology (GO) terms. qPCR validation from WT and
Ndst1f/fLysMCre+ BMDMs (D–F). Secretion of CCL5, CCL2, and CCL7 in the media by BMDMs after 24 hr at 37C (E–G). ACAT activity levels in cell lysates from
(legend continued on next page)
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ance indicated that Ndst1f/fLysMCre+ mice had developed se-
vere type 2 diabetes compared to control mice on the high-fat
diet (Figures 5O and 5P).
The increased fat content in adipose tissue and liver also
correlated with increased macrophage infiltration (F4/80 and
CD11c+ cells, Figures 6A–6C). More F4/80 macrophages
stained for CD11c, suggesting that the cells were in an activated
state (Figure 6D). Expression of inflammatory cytokines, Ccl2,
Ccl5, Ccl7, Ccl8, Tnf-a, and Il6 was elevated as well (Figures
6E–6J), but changes in Il10 expression were modest (Figure 6K).
Accumulation of proinflammatory macrophages in adipose tis-
sue is a hallmark of obesity-associated inflammation, which ex-
acerbates adipogenesis and lipid deposition in tissues (Jin et al.,
2013). We found that the inflammation in BAT correlated with
reduced expression of Prdm16, Pgc-1a and Evolv3, all markers
for BAT associated nonshivering thermogenesis (Figure 6L).
Thus, the macrophage status in the adipose tissue was similar
to that observed in macrophages present in the atherosclerotic
lesions, and their accumulation in adipose tissues is consistent
with enhanced diet-induced obesity in the Ndst1f/fLysMCre+
mice.
Macrophage Proteoglycans Regulate Type I Interferon
Signaling via IFN-b
In search of a molecular mechanism to explain the increased in-
flammatory state of the macrophages in Ndst1f/fLysMCre+mice,
we analyzed promoter motifs of all of the genes that were ex-
pressed at higher levels in the transcriptome data sets. This anal-
ysis revealed that approximately 20% of the genes contain
recognition motifs for interferon regulatory factors (IRFs) and
ISGF3, a complex of STAT1, STAT2, and IRF9 (Figure 7A). These
factors activate expression of genes involved in inflammation in
response to type I interferon stimulation. Macrophages constitu-
tively express a tonic (or basal) level of IFN-b (Gough et al., 2012),
raising the possibility that macrophage proteoglycans modulate
the activity of IFN-b and/or other members of the type I interferon
family. To test this possibility, we challenged macrophages from
wild-type and Ndst1f/fLysMCre+ mice with IFN-b and measured
downstream phosphorylation of STAT1. Although we did not
detect any difference in the baseline level of STAT1 phosphory-
lation,Ndst1f/fLysMCre+macrophages respondedmore robustly
to stimulation by exogenous IFN-b compared to control macro-
phages (Figure 7B). Enzymatic treatment of wild-type macro-
phages with heparin lyase III, which degrades the HS chains
on cell-surface proteoglycans, provided a phenocopy of the
mutant characterized by increased Stat1 phosphorylation in
response to IFN-b (Figure 7C). Treatment of mutant cells with
heparin lyase III amplified their response to exogenous IFN-b
as well, because the mutant macrophages make an undersul-
fated form of HS that remains susceptible to enzymatic digestion
(Figure 7D). Soluble heparin attenuated IFN-b-mediated Stat-1
phosphorylation in wild-type macrophages in a dose-dependentWT and Ndst1f/fLysMCre+ BMDMs (H). qPCR validation from atherosclerotic plaq
after 12 weeks of HFC diet feeding (n = 3–4) (I). Microimages and quantification o
Ldlr/Ndst1f/fLysMCre+mice. Atherosclerotic lesions were stained for CD68-po
Cholesterol ester levels in BMDMafter a 24 hr incubation with 50 mg/ml agLDL in th
or a combination (n = 3) (L). Shown are mean values ± SEM, *p < 0.05 and **p <
Cell Mfashion (Figures 7E and 7F). Stimulation of wild-type BMDMs
with IFN-b increased expression of Ccl5, Ccl7, Acat1, and
Acat2 (Figures 7G–7J) and overall ACAT enzyme activity (Fig-
ure 7K), and provoked foam cell formation in the presence of
agLDL (Figures 7L and S4A).
Type I IFNs signal through the receptors IFNAR1 and IFNAR2
(Gough et al., 2012). Treatment with an antibody against IFNAR1
reduced Acat2 expression in Ndst1f/fLysMCre+ macrophages
(Figure S4D), indicating that the cells were undergoing basal
type I interferon activation in the absence of exogenous inter-
ferons. Cell-surface presentation of IFNAR1 and IFNAR2 did
not differ between Ndst1f/fLysMCre+ and control macrophages
(Figures S4B and S4C). Filter binding assays did not show
interaction of macrophage-derived HS with soluble IFNAR1
and IFNAR2, alone or in complex with a type I IFN (Figure 7M).
In contrast, FGF-2 bound well to macrophage HS. IFNAR1 and
IFNAR2 also did not bind to heparin-Sepharose (Figure S4E).
We next surveyed a number of commercially available forms of
type I IFNs for their capacity to bind macrophage HS and found
that IFN-b bound HS in a dose-dependent manner, whereas
others such as IFN-a4 did not (Figure 7N). We also found that
IFN-b bound to HS from Ndst1f/fLysMCre+ macrophages less
well compared to wild-type-derived HS (Figure 7O). Examination
of the surface charge distribution deduced from the three-
dimensional X-ray structure of IFN-b crystals (Senda et al.,
1995) revealed a significant patch of positively charged amino
acid residues consisting of six arginine and three lysine residues
that could make up a potential binding site for HS (Figure 7P).
This hypothetical HS binding site (arrows) is not part of the
IFN-b interface required for interaction with IFNAR1 (Figure 7Q)
(de Weerd et al., 2013).
DISCUSSION
Based on previous studies showing that syndecan-1 in hepato-
cytes acts as an endocytic receptor for lipoproteins, we antici-
pated that the alteration in HS in macrophages would decrease
the uptake of lipoproteins and protect the macrophage against
foam cell conversion (MacArthur et al., 2007; Stanford et al.,
2009). Other work suggested that reduction in sulfation might
also diminish proteoglycan-mediated subendothelial retention
of LDL particles in the artery wall and delay plaque progression
(Tran-Lundmark et al., 2008). Thus, the increase in atherogenesis
and foam cell conversion and enhanced disposition toward diet-
induced obesity in Ndst1f/fLysMCre+ mice were unexpected
phenotypes. Based on the data, macrophage HSPGs appear
to play an atheroprotective role, by maintaining macrophages
in a quiescent state under basal conditions through dampening
the response to type I interferons, such as IFN-b.
The increased type I interferon activation of themutant macro-
phages leads to infiltration of proinflammatory M1-like or classi-
cally activated macrophages in atherosclerotic lesions. In turn,
the activated macrophages increase monocyte infiltration andues isolated from Ldlr/Ndst1f/fLysMCre and Ldlr/Ndst1f/fLysMCre+ mice
f infiltrated fluorescent bead-labeled Ly6C high monocytes (green) in lesions of
sitive macrophages (red) and with DAPI for nuclei (blue) (n = 3/group) (J and K).
e presence or absence of 10 mg/ml Sandoz 58-035 (ACATi), 30 mMchloroquine,
0.01.
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Figure 5. Reducing Macrophage HSPG Sulfation Promotes Diet-Induced Obesity
Body weights of 8- and 18-week-old male Ndst1f/fLysMCre and Ndst1f/fLysMCre+ mice on a chow diet (n = 4–8) (A). Male Ndst1f/fLysMCre and Ndst1f/f
LysMCre+mice on a HFC diet were weighed weekly (n = 8–10) (B). Wet weights of the liver, eWAT, sWAT, BAT, and biceps femoris muscle after 18 weeks on the
HFC diet (C). Adipocyte diameter distribution in eWAT (D) and H&E staining of liver, eWAT, BAT, and biceps femoris muscle (E) of Ndst1f/fLysMCre and
Ndst1f/fLysMCre+ mice 18 weeks on a HFC diet (n = 4/group). Feeding behavior of 26-week-old Ndst1f/fLysMCre and Ndst1f/fLysMCre+ on a chow or HFC diet
for 18 weeks (n = 4–6) (F). Average VO2 (ml/kg/hr) (G) and average VCO2 (H) in the light and dark cycles. Energy expenditure (I) and respiratory exchange
ratio (RER) (J) in Ndst1f/fLysMCre and Ndst1f/fLysMCre+ mice littermates over a 24 hr period. Average activity in the dark and light cycles (K). Fasting plasma
glucose levels (L), insulin levels before and 15min after an oral glucose gavage (M) and NEFA levels (N) inNdst1f/fLysMCre andNdst1f/fLysMCre+ mice on a HFC
diet (n = 4–6). (O) Glucose tolerance and insulin tolerance (P) tests were performed after 16 weeks on a HFC diet (n = 9). Shown are mean ± SEM, *p < 0.05 and
**p < 0.01.
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Figure 6. Macrophage HSPGs Regulate Adipose Tissue Inflammation in a Model of Diet-Induced Obesity
Expression of F4/80 andCd11c in BAT, eWAT, and liver after 18 weeks on a HFC diet (A and B). Immunostaining images from eWAT of HFD-fedNdst1f/fLysMCre
and Ndst1f/fLysMCre+ mice costained with anti-F4/80 (green) and anti-caveolin-1 (red) antibodies (C). FACS analysis of F4/80+/CD11b+/CD11c+ cells in stromal
vascular cells (n = 4–5/group) (D). Expression of Ccl2, Ccl5, Ccl7, Ccl8, Il6, and Il10 in BAT, eWAT, and liver after 18 weeks on a HFC diet (E–L). Expression of
Ucp1, Prdm16, Pgc-1a, and Evolv3 in BAT liver after 18 weeks on a HFC diet (n = 4–5/group) (M). Shown are mean values ± SEM, *p < 0.05 and **p < 0.01.
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et al., 2007) and increase the propensity of macrophages to
convert to foam cells. The increased inflammation andmonocyte
infiltration is most likely the driving factor for the increased sus-
ceptibility to atherosclerosis in the Ldlr/Ndst1f/fLysMCre+
mice. It is important to note that the bead-labeling method
used in this study may inform on processes other than recruit-Cell Mment such as efferocytosis. It is also possible that fewer macro-
phages emigrate from the lesions in Ldlr/Ndst1f/fLysMCre+
mice. Foam cell formation occurs through multiple mechanisms,
which is why atherosclerosis progresses, albeit at slower rates,
even when one or more pathways mediating foam cell formation
are deleted. One prominent pathway is by uptake of modified
LDL by macrophages (Witztum and Lichtman, 2014). Anotheretabolism 20, 813–826, November 4, 2014 ª2014 Elsevier Inc. 821
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Figure 7. Macrophage HSPGs Regulate Type I Interferon Signaling
Sequence motifs identified by de novo motif analysis of the promoters of upregulated genes in Ndst1f/fLysMCre+ BMDMs (>1.53 from WT) (A). Immunoblot
analysis of STAT1, phosphoSTAT1 (pSTAT1), and b-actin in BMDMs after stimulation with different concentrations of IFN-b for 30 min (B). Immunoblot analysis
and quantification of STAT1 and phosphoSTAT1 (pSTAT1) in BMDMs after stimulation with 0.5 ng/ml IFN-b for 30 min. Cells were preincubated with or without
heparin lyase III at 5 mU/mL for 20 min prior to stimulation (C and D). Immunoblot analysis and quantification of STAT1 and phosphoSTAT1 (pSTAT1) in
WT BMDMs after stimulation with 5 ng/ml IFN-b for 30 min and coincubated with 0, 10, or 100 mg/ml heparin (E and F). qPCR of Ccl5 and Ccl7 from
WT and Ndst1f/fLysMCre+ BMDMs after stimulation with different concentrations of IFN-b for 4 hr (G and H). qPCR of Acat1 and Acat2 from wild-type and
Ndst1f/fLysMCre+ BMDMs after stimulation with different concentrations of IFN-b for 24 hr (I and J). ACAT activity in BMDMs stimulated with or without rmIFN-b
for 24 hr (K). Cholesterol ester levels in BDMDs stimulated with or without rmIFN-b for 24 hr after an additional 24 hr incubation with 50 mg/ml agLDL in the
presence or absence of 10 mg/ml Sandoz 58-035 (ACATi) (L). Binding of BSA, IFNAR-1, IFNAR-2, IFNa4, a combination of IFNa4, IFNAR-1, and IFNAR-2, and
FGF2 to 35S-labeled HS obtained from wild-type BDMDs as determined by filter binding assay (n = 3) (M). Dose-dependent binding of BSA, IFN-b, IFNa4, and
FGF2 to 35S-labeled macrophage HS as determined by filter binding assay (n = 2) (N). Binding of BSA, IFN-b, or FGF2 (600 ng) to 35S-labeled macrophage HS
obtained from either wild-type or and Ndst1f/fLysMCre+ BMDMs as determined by filter binding assay (O). A schematic representation of a crystal structure of
murine IFN-b (Protein Data Bank code 1WU3). Charge distribution at the protein surface is shown (red is negatively and blue is positively charged) (P). Schematic
representation of the crystal structure of murine IFNAR1 (green mesh) in complex with IFN-b (Protein Data Bank code 3WCY). Arrows indicate arginine-rich patch
on IFN-b (Q). Shown are mean values ± SEM, **p < 0.01.
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1989), which in macrophages depends on the LDL receptor-
related protein 1 and the formation of an extracellular acidic, hy-
drolytic compartment, the so-called lysosomal synapse (Haka
et al., 2009). The changes in HSPG composition induced in
Ndst1f/fLysMCre+ mice did not affect binding or uptake of agLDL
in macrophages, suggesting that lysosomal synapse-mediated
uptake may not depend on HSPGs. Previous studies have pro-
posed a role for macrophage HSPGs in regulating apoE levels
at the cell surface, thus modulating cholesterol efflux mediated
by ApoE-HDL complexes (Murphy et al., 2011). However, cell-
surface apoE levels were similar in the mutant and efflux did
not appear to be affected. We cannot exclude the possibility
that more profound changes in HSmight uncover effects on lipo-
protein binding and uptake and cholesterol efflux, but alterations
in these processes do not appear to contribute to the phenotype
of the mutant mice used in this study.
ACAT2 was one of a small set of genes activated in Ndst1f/f
LysMCre+ macrophages, and ACAT1 was elevated as well, sug-
gesting that both isozymes contribute to foam cell conversion.
We also show that IFN-b stimulation induced ACAT1 and
ACAT2 expression and overall ACAT activity in macrophages.
Previous studies showed that ACAT1 is the dominant isoform
expressed in macrophages and that increased expression of
ACAT1 in response to dexamethasone promotes foam cell for-
mation (Yang et al., 2004). Based on enhanced ACAT activity
in cell extracts and the inhibition of foam cell formation by an
ACAT inhibitor, we propose that the increased inflammation in
the Ndst1f/fLysMCre+ macrophages and consequent activation
of ACAT contribute to the greater susceptibility of Ndst1-defi-
cient macrophages to foam cell conversion. Increased IFN-b
stimulation can also enhance survival of lipid-loaded macro-
phages by inhibiting apoptosis (Seimon et al., 2006), resulting
in macrophage accumulation in atherosclerotic lesions. How-
ever, apoptotic genes were downregulated in Ndst1f/fLysMCre+
macrophages, and we did not observe differences in apoptosis
in atherosclerotic lesions.
Although atherosclerosis and obesity are very distinct condi-
tions, they are both characterized by the accumulation M1-
like macrophages and secretion of characteristic cytokines
and chemokines (Jin et al., 2013). Priming of macrophages
in Ndst1f/fLysMCre+ animals apparently suffices to promote
increased macrophage infiltration and inflammation in aorta
and adipose tissue, exacerbating atherosclerosis and obesity
induced by a HFC diet. In the diet-induced obesity study, this
inflammation was most profound in BAT and associated with a
reduction in energy expenditure and BAT activity based on
expression of the relevant genes. It is important to note that ad-
ipose tissue inflammation observed in the diet-induced obesity
study was not observed in our atherosclerosis model (Figures
S1M and S1N).
While IFN-g has been shown to be important in M1 conversion
and foam cell formation, less is known about the impact of type I
interferon signaling. Increased myeloid type I IFN signaling pro-
motes atherosclerosis in mice by stimulating macrophage
recruitment to lesions (Goossens et al., 2010), and inhibition
of IFN-b production can reduce adipose tissue inflammation
in obese mice, consistent with the findings presented here
(Abe et al., 2008). Recently IRF7, a master regulator of type ICell Minterferon response, was found upregulated in liver and adipose
tissue from obese mice compared to lean controls, indicating
increased type I interferon signaling (Wang et al., 2013). IRF7
knockout mice were resistant to diet-induced obesity, insulin
resistance, and inflammation. The IRF7 phenotype, together
with our data, supports that type I interferon signaling is relevant
andmodulates diet-induced obesity, inflammation, and itsmeta-
bolic consequences. Consistent with this idea, inhibition of IFN-b
production by macrophages reduces adipose tissue inflamma-
tion in obese mice (Abe et al., 2008).
Type I interferons are typically expressed in response to viral
or bacterial infection. However, macrophages constitutively ex-
press extremely low amounts of type I IFNs, which nevertheless
exert profound effects based on the ability of neutralizing anti-
bodies to block activation and the lack of macrophage priming
(i.e., setting the homeostatic inflammatory balance through tonic
signaling) in mice with mutations in Ifnar1 or Ifnb (Gough et al.,
2012). Two type I IFNs, IFN-k and IFN-b, bind heparin (Nardelli
et al., 2002), but the biological significance of this interaction
has not been previously established. Based on the findings pre-
sented here, we propose that the capacity to bind HS provides a
mechanism to retain these interferons near their site of secretion
and to buffer their activity by preventing them from interacting
with IFNAR1 and IFNAR2. The retention of heparin-binding
IFNs also provides a pool of effectors that can be potentially
released by alteration of cell-surface HS.
A similar sulfation-dependent model has been proposed for
regulation of Wnt and BMP signaling by HSPGs (Dhoot et al.,
2001; Viviano et al., 2004). The interaction between Wnt and
HS prevents Wnt signaling through frizzled receptors, but acti-
vation of extracellular sulfatases known as SULFs removes a
small subset of sulfate groups located in highly sulfated do-
mains in the chains, generating a soluble pool of Wnt and the
initiation of Wnt signaling. It is conceivable that Sulfs or other
HSPG-modifying enzymes, such as matrix metalloproteases
and heparanase, a heparan-degrading enzyme, might modulate
the bioavailability of IFN-b in the macrophage microenvironment
in a similar way. While we did not observe differences in hepar-
anase expression in macrophages, increased heparanase
expression has been linked to activation of innate immune cells;
expression of inflammatory markers, such as CCL5, CCL2, and
TNF-a; and plaque vulnerability (Blich et al., 2013; Osterholm
et al., 2013).
Our results support a concept in innate immunity in which
HSPGs are important for setting the basal activation threshold
or activation status of macrophages through regulation of tonic
type I IFN signaling. Based on our results we propose a model
wherein HSPGs determine the bioavailability of IFN-b for its
receptors IFNAR1 and IFNAR2 on macrophages (Figure S4F).
Under resting conditions the highly sulfated HS produced by
macrophages maintains type I IFN reception in a quiescent state
through sequestration of IFN-b. Reduction of cell-associated
HSPG or HS composition increases the bioavailability of IFN-b
for its receptors and activatesmacrophages by driving transcrip-
tion of inflammatory genes. Additional research is warranted
to link the exaggerated macrophage response to exogenous
IFN-b ex vivo to the increase in atherosclerosis and obesity.
The amazing sensitivity of this system to small changes in the
degree of sulfation of HS induced by Ndst1 inactivation suggestsetabolism 20, 813–826, November 4, 2014 ª2014 Elsevier Inc. 823
Cell Metabolism
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dividuals more prone to macrophage priming and activation and
downstream sequelae related to chronic inflammation (Shao
et al., 2013; Wei et al., 2011). HS content and sulfation are
decreased in advanced atherosclerotic lesions when compared
to early lesions (Hollmann, 1989; Murata et al., 1997), and a
recent study revealed a positive correlation for heparanase
expression in human vulnerable plaques with expression of in-
flammatory markers as CCL5, CCL2, and TNF-a (Osterholm
et al., 2013). Our data warrant further analysis of macrophage
HS and allelic variants of genes involved in HS metabolism in or-
der to determinewhether HSPG alterations have predictive value
with respect to CVD and obesity.
EXPERIMENTAL PROCEDURES
Mice and Cell Culture
Ndst1f/fLysMCre+ mice were generated by crossing Ndst1f/f mice to LysMCre
transgenic mice (Clausen et al., 1999). Ldlr/mice were crossed with Ndst1f/f
LysMCre+ mice to generate Ldlr/Ndst1f/fLysMCre+ mice. Mice were fed ad
libitum with water and standard rodent chow or a high-fat/high-cholesterol
diet (TD.88137, Harlan Teklad). BMDM were isolated from 8- to 14-week-old
female mice. Peritoneal macrophages were harvested by peritoneal lavage
4 days after i.p. injection of 3 ml of thioglycollate (BD Biosciences). All animals
were housed and bred in vivaria approved by the Association for Assessment
and Accreditation of Laboratory Animal Care located in the School of Medi-
cine, UCSD, following standards and procedures approved by the UCSD Insti-
tutional Animal Care and Use Committee.
Heparan Sulfate Purification and Disaccharide Analysis
BMDMs were treated with a trypsin for 10 min at 37C to release cell-surface
proteoglycans. Disaccharides were quantified by mass spectrometry as
described (Lawrence et al., 2008).
Plasma Lipids and Lipoprotein Distribution and Blood Cell Analysis
Bloodwas obtained by cardiac puncture or via tail the vein. Plasma cholesterol
and triglyceride levels (Sekesui, San Diego, CA, USA) and NEFA levels (WAKO
Diagnostics, VA, USA) were measured by commercially available enzymatic
kits.
Quantification of Aortic Atherosclerosis and Monocyte Labeling
In Vivo
Mice euthanized by isoflurane intoxication were perfused with 10 ml PBS. The
heart and ascending aorta down to the iliac bifurcation were removed and
stained for neutral lipids using Sudan IV. In addition, aortic root cross-sectional
atherosclerosis lesion size was determined using ImageJ software. Classical
Ly-6Clo monocytes were labeled in vivo, and bead infiltration was analyzed
as described (Tacke et al., 2007).
Immunohistochemistry
Mice euthanized by isoflurane intoxication were perfused with PBS and 10%
formalin (Fisher, SF93-4). The upper part of the hearts were placed onto a tis-
sue mold, covered in OCT (Tissue-Tek), and frozen. Serial 10 mm cryosections
from similar parts of the aortic sinus were used for staining. All other tissues
were embedded in paraffin. The extent of staining was measured with ImageJ
software.
RNA Analysis
Total RNA was isolated from homogenized tissue and cells in Trizol and
purified using RNeasy columns (QIAGEN). qPCR (SYBR Green) analysis
was performed on an Applied Biosystems 7300 Real-time PCR system
(Invitrogen). Global gene expression wasmeasured bymicroarray analysis us-
ing the Affymetrix HT_MG430A array. Data are uploaded to the Gene Expres-
sion Omnibus and can be accessed via the following link: http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?token=sxkbymogflovlsn&acc=GSE51009.824 Cell Metabolism 20, 813–826, November 4, 2014 ª2014 ElsevierLipoprotein Binding and Uptake
Human LDL (density d 1.019–1.063 g/mL) and HDL (density d 1.063–1.21 g/mL)
were isolated from plasma by buoyant density ultracentrifugation and quanti-
fied by BCA protein assay (Pierce).
Foam Cell Assay and Reverse Cholesterol Transport
Macrophage cholesterol ester content was quantitated by the Amplex Red
Cholesterol Assay Kit (Life Science Technologies, San Diego). Cholesterol
ester content was calculated by subtracting free cholesterol from total choles-
terol for each sample. Cholesterol efflux from BMDMs was performed as
described (Nakaya et al., 2011).
Indirect Calorimetry
Mice were placed into Comprehensive Lab Animal Monitoring System
(CLAMS; Columbus Instruments). Rates of O2 consumption (VO2; ml/kg/h)
and CO2 production (VCO2) were measured for each chamber every 17 min
throughout the study.
Glucose Tolerance and Insulin Tolerance Test
Mice were fasted for 5 hr. Blood samples were collected via tail vein bleeding
immediately before and at 15, 30, 60, 90, and 120 min after oral glucose (2 mg/
g body weight) gavage for glucose tolerance test (GTT), after intraperitoneal in-
jection of insulin (0.5 U/kg body weight) for insulin tolerance test (ITT). Blood
was immediately used for determination of glucose levels via the Accu-Chek
Aviva glucose monitoring system (Roche Applied Science GmbH, Mannheim,
Germany). Insulin levels were determined via the ultrasensitive rat insulin
ELISA kit (Chrystal Chem, Downers Grove, IL).
Nitrocellulose Filter Binding Assay
Recombinant IFNAR1 (Life Science Technologies), IFNAR2, IFN-a4, and IFN-b
(400 or 800 ng; PBL Interferon) were incubated with 10,000 counts of 35S-
labeled BMDM HS for 1 hr at 22C. The mixtures were applied to a prewashed
nitrocellulose membrane to determine HS binding.
Stromal Vascular Fraction Isolation
Stromal vascular cells were prepared from collagenase-digested adipose tis-
sue, and FACS analysis of stromal vascular cells for macrophage content and
subtypes was performed. The antibodies for surface staining were F4/80
(BM8), Ly6C (AL-21), CD11b (M1/70), and CD11c (N418) (eBioscience, San
Diego, CA).
Statistics
Microarray results were normalized using RMA in the ‘‘affy’’ package, and dif-
ferential expression p values were calculated using the ‘‘limma’’ package and
adjusted for multiple comparisons by Benjamini-Hochberg procedure. All
other data were analyzed by Student’s t test or two-way ANOVA and pre-
sented as mean ± SEM. Statistical analyses were performed using Prism soft-
ware (version 5; GraphPad Software). p values less than 0.05 were considered
significant.
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